These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36196083)

  • 1. Reduced RNA adenosine-to-inosine editing in hippocampus vasculature associated with Alzheimer's disease.
    Crooke PS; Tossberg JT; Heinrich RM; Porter KP; Aune TM
    Brain Commun; 2022; 4(5):fcac238. PubMed ID: 36196083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine-to-Inosine RNA Editing of Alu Double-Stranded (ds)RNAs Is Markedly Decreased in Multiple Sclerosis and Unedited Alu dsRNAs Are Potent Activators of Proinflammatory Transcriptional Responses.
    Tossberg JT; Heinrich RM; Farley VM; Crooke PS; Aune TM
    J Immunol; 2020 Nov; 205(10):2606-2617. PubMed ID: 33046502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease.
    Crooke PS; Tossberg JT; Porter KP; Aune TM
    J Immunol; 2021 Apr; 206(8):1691-1696. PubMed ID: 33782089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alu RNA Structural Features Modulate Immune Cell Activation and A-to-I Editing of Alu RNAs Is Diminished in Human Inflammatory Bowel Disease.
    Aune TM; Tossberg JT; Heinrich RM; Porter KP; Crooke PS
    Front Immunol; 2022; 13():818023. PubMed ID: 35126398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection.
    Crooke PS; Tossberg JT; Porter KP; Aune TM
    Curr Res Immunol; 2021; 2():52-59. PubMed ID: 33969287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive adenosine-to-inosine editing detected in Alu repeats of antisense RNAs reveals scarcity of sense-antisense duplex formation.
    Kawahara Y; Nishikura K
    FEBS Lett; 2006 Apr; 580(9):2301-5. PubMed ID: 16574103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of widespread ultra-edited human RNAs.
    Carmi S; Borukhov I; Levanon EY
    PLoS Genet; 2011 Oct; 7(10):e1002317. PubMed ID: 22028664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered RNA Editing in Atopic Dermatitis Highlights the Role of Double-Stranded RNA for Immune Surveillance.
    Karmon M; Kopel E; Barzilai A; Geva P; Eisenberg E; Levanon EY; Greenberger S
    J Invest Dermatol; 2023 Jun; 143(6):933-943.e8. PubMed ID: 36502941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity.
    Roth SH; Levanon EY; Eisenberg E
    Nat Methods; 2019 Nov; 16(11):1131-1138. PubMed ID: 31636457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What do editors do? Understanding the physiological functions of A-to-I RNA editing by adenosine deaminase acting on RNAs.
    Heraud-Farlow JE; Walkley CR
    Open Biol; 2020 Jul; 10(7):200085. PubMed ID: 32603639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy.
    Garland KM; Kwiatkowski AJ; Tossberg JT; Crooke PS; Aune TM; Wilson JT
    Cancer Res Commun; 2023 Sep; 3(9):1800-1809. PubMed ID: 37691856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter from the editor: Adenosine-to-inosine RNA editing in Alu repeats in the human genome.
    Levanon K; Eisenberg E; Rechavi G; Levanon EY
    EMBO Rep; 2005 Sep; 6(9):831-5. PubMed ID: 16138094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes.
    Bazak L; Haviv A; Barak M; Jacob-Hirsch J; Deng P; Zhang R; Isaacs FJ; Rechavi G; Li JB; Eisenberg E; Levanon EY
    Genome Res; 2014 Mar; 24(3):365-76. PubMed ID: 24347612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alu elements shape the primate transcriptome by cis-regulation of RNA editing.
    Daniel C; Silberberg G; Behm M; Öhman M
    Genome Biol; 2014 Feb; 15(2):R28. PubMed ID: 24485196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced levels of protein recoding by A-to-I RNA editing in Alzheimer's disease.
    Khermesh K; D'Erchia AM; Barak M; Annese A; Wachtel C; Levanon EY; Picardi E; Eisenberg E
    RNA; 2016 Feb; 22(2):290-302. PubMed ID: 26655226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALU A-to-I RNA Editing: Millions of Sites and Many Open Questions.
    Schaffer AA; Levanon EY
    Methods Mol Biol; 2021; 2181():149-162. PubMed ID: 32729079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alu sequences in undifferentiated human embryonic stem cells display high levels of A-to-I RNA editing.
    Osenberg S; Paz Yaacov N; Safran M; Moshkovitz S; Shtrichman R; Sherf O; Jacob-Hirsch J; Keshet G; Amariglio N; Itskovitz-Eldor J; Rechavi G
    PLoS One; 2010 Jun; 5(6):e11173. PubMed ID: 20574523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consistent levels of A-to-I RNA editing across individuals in coding sequences and non-conserved Alu repeats.
    Greenberger S; Levanon EY; Paz-Yaacov N; Barzilai A; Safran M; Osenberg S; Amariglio N; Rechavi G; Eisenberg E
    BMC Genomics; 2010 Oct; 11():608. PubMed ID: 21029430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome-wide profiling of A-to-I RNA editing by Slic-seq.
    Wei Q; Han S; Yuan K; He Z; Chen Y; Xi X; Han J; Yan S; Chen Y; Yuan B; Weng X; Zhou X
    Nucleic Acids Res; 2023 Sep; 51(16):e87. PubMed ID: 37470992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A-to-I editing of coding and non-coding RNAs by ADARs.
    Nishikura K
    Nat Rev Mol Cell Biol; 2016 Feb; 17(2):83-96. PubMed ID: 26648264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.